Complex interplay among apoptosis factors: RB, P53, E2F, TGF-β, cell cycle inhibitors and the BCL2 gene family

Pharmacological Research

Volumn 35, Issue 4, 1997, Pages 257-261

  Chiarugi, Vincenzo ^a   Magnelli, Lucia ^a   Cinelli, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Apoptosis; Bcl2; p53

Indexed keywords

ELONGATION FACTOR 2; PROTEIN P53; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL CYCLE; MULTIGENE FAMILY; PRIORITY JOURNAL; REVIEW;

EID: 0031126857     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0140     Document Type: Article

References (46)

1. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci. 93:1996;2239-2244.
2. Hole J, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT. Apoptosis=molecular regulation of cell death. Eur J Biochem. 236:1996;1-26.
3. Wu X, Levine AJ. p53 and E2F cooperate to mediate apoptosis. Proc Natl Acad Sci USA. 91:1994;3602-3606.
4. Lam EWF, La Thangue NB. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Op Cell Biol. 6:1994;859-866.
5. Ewen ME. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:1994;45-66.
6. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in bcl-2 gene. Cancer Res. 54:1994;3131-3135.
7. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expressionin vitroin vivo. Oncogene. 9:1994;1799-1805.
8. Ryan JJ, Danish R, Gottlieb CA, Clarke MF. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol. 13:1993;711-719.
9. Chiarugi V, Magnelli L, Cinelli M, Basi G. Apoptosis and the cell cycle. Cell Mol Biol Res. 40:1994;8-17.
10. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 9:1994;1807-1812.
11. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
12. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
13. 1. Cell. 75:1993;805-816.
14. 1. Curr Op Cell Biol. 6:1994;842-846.
15. Sherr CJ. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
16. Sherr CJ. Cancer cell cycles. Science. 274:1996;1672-1673.
17. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 211:1994;90-98.
18. INK4. Science. 267:1995;249-252.
19. Kip1. Cell. 78:1994;59-66.
20. Derynch R. TGF-β TIBS. 19:1994;548-553.
21. Hannon GJ, Denetrick D, Beach D. Isolation of RB related p130 through its interaction with CDK2 and cyclins. Gene Dev. 7:1993;2378-2391.
22. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewsky S, Reed JC, Hoffman B, Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 9:1994;1791-1798.
23. Price BD, Calderwood SK. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene. 8:1993;3055-3062.
24. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
25. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
26. Lowe SH, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
27. McIlwrath AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res. 54:1994;3718-3722.
28. Hupp TR, Lane DP. Two distinct signalling pathways activate the latent DNA-binding function in p53 in a casein kinase II-independent manner. J Biol Chem. 270:1995;18165-18174.
29. Takenaka I, Morin F, Seizinger BR, Kley N. Regulation of the sequence-specific DNA-binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem. 270:1995;5405-5411.
30. Magnelli L, Cinelli M, Chiarugi V. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect ts-p53/K562 from apoptosis. Biochem Biophys Res Commun. 215:1995;641-645.
31. Baudier J, Dalphin C, Grunwald D, Khochbin S, Lawrence JJ. Characterization of the tumour suppressor protein p53 as a protein kinase C substrate. Proc Natl Acad Sci USA. 89:1992;11627-11631.
32. Oren M. p53 the ultimate tumor suppressor gene? FASEB J. 6:1992;3169-3176.
33. Skouv J, Jensen PO, Forchhammer J, Larsen JK, Lund LR. Tumour promoting phorbol esters transiently down modulates the p53 level and block the cell cycle. Cell Growth Diff. 5:1994;329-340.
34. Wright SC, Zhong J, Larrick JW. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8:1994;654-660.
35. Lampe J. Gap junction closure by tumours promoters. J Cell Biol. 127:1994;1895-1899.
36. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9:1994;3743-3751.
37. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts byc-myc. Cell. 69:1992;119-128.
38. Chiou SK, Rao L, White E. Bcl2 blocks p53-dependent apoptosis. Mol Cell Biol. 14:1994;2556-2563.
39. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 80:1992;879-886.
40. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizesin vivo. Cell. 74:1993;609-619.
41. Baffy G, Miyashita T, Williamson JR, Reed JC. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3 dependent hematopoietic cell line is associated with re-partitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem. 268:1993;6511-6519.
42. Magnelli L, Cinelli M, Turchetti A, Chiarugi V. Apoptosis induction in 32D cells by IL-3 withdrawal is preceded by a drop in the intracellular calcium level. Biochem Biophys Res Commun. 194:1993;1394-1397.
43. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1994;1274-1277.
44. Hockembery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxydant pathway to prevent apoptosis. Cell. 75:1993;241-251.
45. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Van Ommen GB, Kluin PM. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res. 54:1994;256-260.
46. De Jong D, Prins FA, Mason DY, Reed JC, Van Ommen GB, Kluin PM. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res. 54:1994;256-260.